HomeRNTX • NASDAQ
add
Rein Therapeutics Inc
Previous close
$1.83
Day range
$1.79 - $1.92
Year range
$1.35 - $5.19
Market cap
42.01M USD
Avg Volume
28.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.80M | -20.61% |
Net income | -40.98M | -458.40% |
Net profit margin | — | — |
Earnings per share | -0.26 | — |
EBITDA | -5.80M | 20.04% |
Effective tax rate | 3.63% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.86M | -25.69% |
Total assets | 62.19M | -41.33% |
Total liabilities | 7.80M | 1.13% |
Total equity | 54.39M | — |
Shares outstanding | 21.99M | — |
Price to book | 4.26 | — |
Return on assets | -17.42% | — |
Return on capital | -19.37% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -40.98M | -458.40% |
Cash from operations | -4.81M | 53.69% |
Cash from investing | — | — |
Cash from financing | 1.00K | -99.99% |
Net change in cash | -4.81M | -191.76% |
Free cash flow | -3.16M | -79.78% |
About
Founded
2001
Headquarters
Website
Employees
11
